Cipla vs Dr. Reddy's Labs

403 views 27 slides Feb 02, 2021
Slide 1
Slide 1 of 27
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27

About This Presentation

A detailed comparison between the financials


Slide Content

A Comparison between the financials of: Cipla & Dr.Reddy’s Labs Name- Roshan Kumar Class Roll N o- 2022

COMPANY PROFILE AND HISTORY

Cipla Ltd is one of the leading pharmaceutical companies in India. The company focuses on development of new formulations and has a wide range of pharmaceutical products. The product portfolio includes over 1500 products across wide range of therapeutic categories. Cipla Ltd was incorporated in the year 1935 with the name Chemical Industrial & Pharmaceutical Laboratories Ltd. Khwaja Abdul Hamied the founder of Cipla gave the company all his patent and proprietary formulas for several drugs and medicines without charging any royalty. On August 17 1935 Cipla was registered as a public limited company with an authorized capital of Rs 6 lakh . .

Cipla in 1940

About Cipla  Its today's share price is 795.35. Its current market capitalisation stands at Rs 66097.07 Cr. In the latest quarter, company has reported Gross Sales of Rs. 135553.4 Cr and Total Income of Rs.135729.1 Cr . Cipla announced its entry into the anti-fungal product category with Clocip , a skin infection solution. Cipla launched Cipremi , an experimental anti-viral drug remdesivir , having Emergency Use Authorisation (EUA) treatment for adult and paediatric patients hospitalized with suspected or laboratory confirmed COVID-19 infection Received approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Aerosol 90 mcg (base)/actuation Acquired four key brands from Wanbury for up to Rs. 89 crore (US$ 12.73 million) in order to strengthen its women’s health segment

COMPANY PROFILE AND HISTORY

Dr Reddy's Laboratories Ltd (DRL) is an integrated global pharmaceutical company committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services &Active Ingredients Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs) custom pharmaceutical services generics biosimilars and differentiated formulations Dr Reddy's Laboratories was incorporated in the year 1984 in Hyderabad. The company was established by Dr Anji Reddy with an initial capital outlay of Rs 25 lakh . The company made their beginning with the manufacture of Active Pharmaceutical Ingredients and Intermediates (API) and commenced operations with a single drug in a 60-tonne facility near Hyderabad India.

ABOUT DR. REDDY’S LAB It is among the top three API players in world. Dr Reddy's, a global pharmaceutical company, has its headquarters located in India. It has a global presence in more than 100 countries, with subsidiaries in the US, UK, Russia, Germany and Brazil; joint ventures in China, South Africa and Australia; representative offices in 16 countries and third–party distribution set ups in 21 countries. It is first pharmaceutical company in Asia, outside Japan, to be listed on the NYSE. It is largest player in the custom pharmaceutical services (CPS) business in India.The pharma major has launched brands like Ciprolet , Nise , Enam , Stamlo , Omez , and Ketorol among others.

CIPLA

CIPLA This is the weekly chart showing the share price of cipla for last 1 year

Cashflow statements of Cipla

Balance sheet data of cipla

Quarterly Results

REDDY’s LTD. FINACIAL STATEMENT & RATIO ANALYSIS .

Dr.Reddy’s

This is the weekly chart showing the share price of cipla for last 1 year

Cashflow statements of Dr.Reddys

Balance sheet data of Dr. Reddy’s

Quarterly Results

Conclusion Both the companies are good fundamentally but given the rise that we have seen in pharma stocks after the pandemic ,the pharma stocks are availaible at a very high price to invest in. As the stock price is high there is more risk involved in investing these stocks with less returns . But if I have to choose between these two stocks I would rather choose Dr.Reddy’s over cipla as it has given a consistent return as compared to cipla , so dr reddy may prove a good investment in long term.

Thank You!
Tags